Uday R Popat

62PUBLICATIONS
195CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical mycologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Sep 18, 2026
Outcomes of adult patients with Li-Fraumeni syndrome and myeloid neoplasms.

|Jul 31, 2026
Phase I/II Trial of Evomela for Autologous Transplant in Myeloma: Schedule Optimization and Matched Comparison with MEL200.

|May 27, 2026
Long-term outcomes of azacitidine, venetoclax, and gilteritinib in newly diagnosed FLT3-mutated AML.

|May 13, 2026
Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant.

|May 06, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

|Apr 26, 2026
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

Pageof 11

Frequent Collaborators

25 joint publications

Richard E Champlin

16 joint publications

Naval G Daver

15 joint publications

Tapan M Kadia

15 joint publications

Rohtesh S Mehta